Skip to main content
TipRanks
Go Ultimate75% OFF

Bioray Biotech Co., Ltd (7561) Financial Statements

Bioray Biotech Co., Ltd Financial Overview

Bioray Biotech Co., Ltd's market cap is currently NT$478.36M. The company's EPS TTM is NT$0.65; its P/E ratio is 24.46; and it has a dividend yield of 5.97%. Bioray Biotech Co., Ltd has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 222.72MNT$ 201.71MNT$ 191.83MNT$ 190.60MNT$ 148.02M
Gross ProfitNT$ 90.57MNT$ 79.03MNT$ 77.65MNT$ 80.51MNT$ 67.29M
Operating IncomeNT$ 37.90MNT$ -4.32MNT$ -19.33MNT$ -235.00KNT$ -8.11M
EBITDANT$ 61.49MNT$ 27.69MNT$ 12.13MNT$ 24.27MNT$ 13.86M
Net IncomeNT$ 32.25MNT$ 1.00MNT$ -11.56MNT$ 500.00KNT$ -7.19M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 204.92MNT$ 178.21MNT$ 97.02MNT$ 139.06MNT$ 126.31M
Total AssetsNT$ 536.58MNT$ 543.63MNT$ 542.65MNT$ 598.63MNT$ 466.18M
Total DebtNT$ 46.29MNT$ 85.78MNT$ 69.79MNT$ 100.92MNT$ 53.47M
Net DebtNT$ -158.63MNT$ -92.43MNT$ -27.23MNT$ -38.15MNT$ -72.84M
Total LiabilitiesNT$ 83.57MNT$ 122.90MNT$ 108.75MNT$ 147.16MNT$ 102.25M
Stockholders' EquityNT$ 453.01MNT$ 420.73MNT$ 433.90MNT$ 451.47MNT$ 363.92M
Cash Flow
Free Cash FlowNT$ 71.36MNT$ 13.35MNT$ -10.95MNT$ -57.90MNT$ -6.71M
Operating Cash FlowNT$ 71.73MNT$ 16.65MNT$ -762.00KNT$ 2.48MNT$ 8.83M
Investing Cash FlowNT$ 727.00KNT$ 53.72MNT$ -12.55MNT$ -59.63MNT$ -19.79M
Financing Cash FlowNT$ -45.75MNT$ 10.82MNT$ -28.73MNT$ 69.92MNT$ -8.64M

Currency in TWD

Bioray Biotech Co., Ltd Earnings and Revenue History

-120M0120M240M-8 %0 %8 %16 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Bioray Biotech Co., Ltd Liabilities to Assets

0250M500M750M0 %10 %20 %30 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Bioray Biotech Co., Ltd Cash Flow

-150M-100M-50M050M100M150M201720182019202020212022202320242025OperatingInvestingFinancing

Bioray Biotech Co., Ltd Forecast EPS vs Actual EPS